AI Intelligence Bureau focuses on independent market commentary, market review, and in-depth perspectives in the AI sector, continuously delivering industry trend interpretations, hot-topic analysis, and value insights to help users quickly grasp AI market dynamics and direction.
In Q3 2026, generative AI in drug discovery officially entered the clinical validation stage. With multiple AI-designed innovative drugs ent
As 2026 reaches its midpoint, the global AI industry has shifted from technological hype to business rationality. Hong Kong's AI industry ch
An in-depth analysis of the revolutionary application of AI technology in the investment sector in 2026. From multi-agent collaboration to e
In 2026, the AI industry enters a critical period of commercial implementation, with technological breakthroughs and business model innovati
In Q3 2026, the global AI industry's focus shifts from cloud computing to on-device devices, accelerating the deployment of multimodal LLMs
As general-purpose GPUs hit cost-performance bottlenecks in inference, the global AI chip architecture is reaching a historic turning point
In early August 2026, Tesla announced the open-sourcing of its FSD V12 end-to-end neural network architecture to global ecosystem partners.
In early August 2026, a major breakthrough in the yield of NVIDIA's next-generation GB300 AI chip forces data centers to fully transition to
In Q3 2026, with the large-scale implementation of 'World Models' in autonomous driving and embodied AI, AI compute demand is shifting rapid
Details of the BIS 'AI Hawkeye' system, secretly trialed in early August 2026, have surfaced. Using generative AI to parse policy texts and
